Minimum effective dose of midazolam for sedation of mechanically ventilated neonates

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 5, 2005, Pages 479-485

  Treluyer, Jean Marc ^a,e   Zohar, S ^b   Rey, E ^a   Hubert, P ^c   Iserin, F ^c   Jugie, M ^d   Lenclen, R ^d   Chevret, S ^b   Pons, G ^a  

^a Université Paris V ^*  (United States)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d Hôpital de Poissy St Germain   (France)

^e HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Continual reassessment method; Dose finding study; Midazolam; Neonates; Stopping rules for decision making

Indexed keywords

MIDAZOLAM;

AGITATION; ARTICLE; ARTIFICIAL VENTILATION; BAYES THEOREM; CLINICAL ARTICLE; CONTROLLED STUDY; CRYING; DOSE RESPONSE; FACIAL EXPRESSION; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; MALE; NEWBORN; PERINATAL PERIOD; RESPIRATORY DISTRESS SYNDROME; SEDATION;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; MALE; MIDAZOLAM; RESPIRATION, ARTIFICIAL;

EID: 27744512779     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00678.x     Document Type: Article

References (24)

1. Quinn MW, Wild J, Dean HG, Hartley R, Rushforth JA, Puntis JW, Levene MI (1993) Randomised double-blind controlled trial of effect of morphine on catecholamine concentrations in ventilated pre-term babies. Lancet, 342, 324-327.
2. Greenough A, Morley C, Davis J (1983) Interaction of spontaneous respiration with artificial ventilation in preterm babies. Journal of Pediatrics, 103, 769-773.
3. Perlman JM, Goodman S, Kreusser KL, Volpe JJ (1985) Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome. New England Journal of Medicine, 312, 1353-1357.
4. Hartwig S, Roth B, Theisohn M (1991) Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. European Journal of Pediatrics, 150, 784-788.
5. Pellier I, Monrigal JP, Le Moine P, Rod B, Rialland X, Granry JC (1999) Use of intravenous ketamine-midazolam association for pain procedures in children with cancer. A prospective study. Paediatric Anaesthesia, 9, 61-68.
6. Rosen DA, Rosen KR (1991) Midazolam for sedation in the paediatric intensive care unit. Intensive Care Medicine, 17 (Suppl. 1), S15-S19.
7. Hogberg L, Nordvall M, Tjellstrom B, Stenhammar L (1995) Intranasal versus intravenous administration of midazolam to children undergoing small bowel biopsy. Acta Paediatrica, 84, 1429-1431.
8. Ng E, Taddio A, Ohlsson A (2000) Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database of Systematic Review, CD002052.
9. Anand KJS, McIntosh N, Lagercrantz H, Pelausa E, Young TE, Vasa R (1999) Analgesia and sedation in preterm neonates who require ventilatory support - results from the NOPAIN trial. Archives of Pediatrics and Adolescent Medicine, 153, 331-338.
10. Jacqz-Aigrain E, Daoud P, Burtin P, Desplanques L, Beaufils F (1994) Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies [see comments]. Lancet, 344, 646-650.
11. Desfrere L, Zohar S, Morville P et al. (2003) Dose-finding study of ibuprofen in patent ductus arteriosus using the continual assessment method. Journal of Clinical Pharmacy and Therapeutics, 30, 121-132.
12. O'Quigley J, Pepe M, Fisher L (1990) Continual reassessment method: a practical design for phase 1 clinical trials in cancer. Biometrics, 46, 33-48.
13. Zohar S, Chevret S (2001) The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies. Statistics in Medicine, 20, 2827-2843.
14. de Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN (2001) Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clinical Pharmacology and Therapeutics, 70, 525-531.
15. Nahara MC, McMorrow J, Jones PR, Anglin D, Rosenberg R (2000) Pharmacokinetics of midazolam in critically ill pediatric patients. European Journal of Drug Metabolism and Pharmacokinetics, 25, 219-221.
16. Jacqz-Aigrain E, Daoud P, Burtin P, Maherzi S, Beaufils F (1992) Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. European Journal of Clinical Pharmacology, 42, 329-332.
17. Jacqz-Aigrain E, Wood C, Robieux I (1990) Pharmacokinetics of midazolam in critically ill neonates. European Journal of Clinical Pharmacology, 39, 191-192.
18. Burtin P, Jacqz-Aigrain E, Girard P et al (1994) Population pharmacokinetics of midazolam in neonates. Clinical Pharmacology and Therapeutics, 56, 615-625.
19. Lee TC, Charles BG, Harte GJ, Gray PH, Steer PA, Flenady VJ (1999) Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics. Anesthesiology, 90, 451-457.
20. Harte GJ, Gray PH, Lee TC, Steer PA, Charles BG (1997) Haemodynamic responses and population pharmacokinetics of midazolam following administration to ventilated, preterm neonates. Journal of Paediatrics and Child Health, 33, 335-338.
21. Barrier G, Attia J, Mayer MN, Amiel-Tison C, Shnider SM (1989) Measurement of post-operative pain and narcotic administration in infants using a new clinical scoring system. Intensive Care Medicine, 15 (Suppl. 1), S37-S39.
22. Fetus and Newborn Committee (2000) Prevention and management of pain and stress in the neonate. American Academy of Pediatrics. Committee on Fetus and Newborn. Committee on Drugs. Section on Anesthesiology. Section on Surgery. Canadian Paediatric Society. Pediatrics, 105, 454-461.
23. Van den Anker J, Sauer P. (1992) The use of midazolam in the preterm neonate. European Journal of Pediatrics, 151, 152.
24. Burtin P, Daoud P, Jacqz-Aigrain E, Mussat P, Moriette G (1991) Hypotension with midazolam and fentanyl in the newborn. Lancet, 337, 1545-1546.